These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 19019755
1. Chronic oral therapy with enalapril in normal ponies. Sleeper MM, McDonnell SM, Ely JJ, Reef VB. J Vet Cardiol; 2008 Dec; 10(2):111-5. PubMed ID: 19019755 [Abstract] [Full Text] [Related]
2. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses. Gardner SY, Atkins CE, Sams RA, Schwabenton AB, Papich MG. J Vet Intern Med; 2004 Dec; 18(2):231-7. PubMed ID: 15058776 [Abstract] [Full Text] [Related]
3. Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing. Edeki T, Johnston A, Li Kam Wa E, Turner P. Int J Clin Pharmacol Ther; 1994 Mar; 32(3):142-6. PubMed ID: 8205376 [Abstract] [Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses. Gómez-Díez M, Muñoz A, Caballero JM, Riber C, Castejón F, Serrano-Rodríguez JM. Res Vet Sci; 2014 Aug; 97(1):105-10. PubMed ID: 24972864 [Abstract] [Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of a nitric oxide-releasing derivative of enalapril in male beagles. Okuyama CE, Mendes GD, Faro R, Rezende VM, Lagos RM, Astigarraga RE, Antunes E, De Nucci G. Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):290-5. PubMed ID: 17324140 [Abstract] [Full Text] [Related]
6. Modulation of acute transient exercise-induced hypertension after oral administration of four angiotensin-converting enzyme inhibitors in normotensive horses. Muñoz A, Esgueva M, Gómez-Díez M, Serrano-Caballero JM, Castejón-Riber C, Serrano-Rodríguez JM. Vet J; 2016 Feb; 208():33-7. PubMed ID: 26626097 [Abstract] [Full Text] [Related]
8. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach. Ribeiro W, Muscará MN, Martins AR, Moreno H, Mendes GB, de Nucci G. Eur J Clin Pharmacol; 1996 Feb; 50(5):399-405. PubMed ID: 8839663 [Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism. Meurs KM, Stern JA, Atkins CE, Adin D, Aona B, Condit J, DeFrancesco T, Reina-Doreste Y, Keene BW, Tou S, Ward J, Woodruff K. J Renin Angiotensin Aldosterone Syst; 2017 Feb; 18(4):1470320317737184. PubMed ID: 29069972 [Abstract] [Full Text] [Related]
10. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril. Tsuruoka S, Kitoh Y, Kawaguchi A, Sugimoto K, Hayasaka T, Saito T, Fujimura A. J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777 [Abstract] [Full Text] [Related]
11. [Examinations on the pharmacokinetics and compatibility of enalapril in racing pigeons]. Pees M, Pees K, Abraham G, Lierz M, Ungemach FR, Krautwald-Junghanns ME. Tierarztl Prax Ausg K Kleintiere Heimtiere; 2013 Feb; 41(5):319-25. PubMed ID: 24127029 [Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme in bovine, feline, and human ocular tissues. Ferrari-Dileo G, Ryan JW, Rockwood EJ, Davis EB, Anderson DR. Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):876-81. PubMed ID: 2836331 [Abstract] [Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease. Steele JL, Henik RA, Stepien RL. Vet Ther; 2002 Jun; 3(2):157-66. PubMed ID: 19750747 [Abstract] [Full Text] [Related]
14. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril. Verbeeck RK, Kanfer I, Löbenberg R, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Polli JE, Parr A, Shah VP, Mehta M, Dressman JB. J Pharm Sci; 2017 Aug; 106(8):1933-1943. PubMed ID: 28435140 [Abstract] [Full Text] [Related]
15. Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea. Sakamoto K, Sugimoto K, Sudoh T, Fujimura A. Hypertens Res; 2005 Mar; 28(3):243-7. PubMed ID: 16097368 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers. Beermann B, Till AE, Gomez HJ, Hichens M, Bolognese JA, Junggren I. Biopharm Drug Dispos; 1989 Mar; 10(4):397-409. PubMed ID: 2547465 [Abstract] [Full Text] [Related]
17. Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects. Weisser K, Schloos J, Lehmann K, Düsing R, Vetter H, Mutschler E. Eur J Clin Pharmacol; 1991 Mar; 40(1):95-9. PubMed ID: 1647954 [Abstract] [Full Text] [Related]
18. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. Lu S, Jiang K, Qin F, Lu X, Li F. J Pharm Biomed Anal; 2009 Jan 15; 49(1):163-7. PubMed ID: 19046843 [Abstract] [Full Text] [Related]
19. Different accumulation of temocapril and enalapril during repeated dosing in elderly patients. Arakawa M, Ohmori M, Harada K, Araki N, Saitoh T, Fujimura A. Br J Clin Pharmacol; 2005 Apr 15; 59(4):489-90. PubMed ID: 15801948 [No Abstract] [Full Text] [Related]
20. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Li P, Callery PS, Gan LS, Balani SK. Drug Metab Dispos; 2007 Jul 15; 35(7):1023-31. PubMed ID: 17392396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]